Endarterectomy, Carotid Clinical Trial
Official title:
Effects of Dexmedetomidine on the Intraoperative Electroencephalogram During Endarterectomy Surgery
Verified date | May 2017 |
Source | University of California, Davis |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
During elective carotid endarterectomy surgery, dexmedetomidine, an FDA approved medication, is now given as part of our standard anesthetic regimen based upon its reported ability to decrease anesthetic requirements and improve the peri-operative hemodynamic profile without compromising the EEG monitoring that is used during these procedures. Although this is consistent with our clinical impression, the effects of dexmedetomidine on the perioperative course and EEG monitoring have not been objectively evaluated at our institution.
Status | Completed |
Enrollment | 22 |
Est. completion date | November 2009 |
Est. primary completion date | May 2009 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Patients undergoing elective carotid endarterectomy Exclusion Criteria: - Emergency surgery |
Country | Name | City | State |
---|---|---|---|
United States | University of California, Davis Medical Center | Sacramento | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Davis |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Effects of Dexmedetomidine on the Intraoperative Electroencephalogram During Endarterectomy Surgery | Data collection and analysis complete. Permanently closed. | April 2005 - November 2009 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00294606 -
Comparison of the Effects of Phenylephrine and Norepinephrine on Cardiac Function During Carotid Artery Surgery
|
N/A | |
Completed |
NCT02808754 -
Remote Ischemic Preconditioning for Carotid Endarterectomy
|
N/A | |
Completed |
NCT00288899 -
Benefits of 'Repeat Back' Protocols Within A Computer-Based Informed Consent Program
|
Phase 1 |